Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System

American Journal of Medicine

Volumn 130, Issue 1, 2017, Pages 93.e1-93.e7

  Martin, Jason ^a,b   Halm, Ethan A ^a,b,c,d   Tiro, Jasmin A ^c,d   Merchant, Zahra ^a   Balasubramanian, Bijal A ^d,e   McCallister, Katharine ^c   Sanders, Joanne M ^c   Ahn, Chul ^c,d   Bishop, Wendy Pechero ^c,d   Singal, Amit G ^a,b,c,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e Health Science Centre   (United States)

Author keywords

Colonoscopy; Colorectal cancer screening; Fecal immunochemical test; Randomized controlled trial; Safety net health system

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY NET HEALTH SYSTEM; AGE; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; HEALTH INSURANCE; INSURANCE; OCCULT BLOOD; SAFETY NET HOSPITAL; STATISTICS AND NUMERICAL DATA; TEXAS;

AGE FACTORS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MIDDLE AGED; OCCULT BLOOD; RETROSPECTIVE STUDIES; SAFETY-NET PROVIDERS; TEXAS;

EID: 85000434651     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2016.07.028     Document Type: Article

References (26)

1. 1 Siegel, R., Desantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA Cancer J Clin 64 (2014), 104–117.
2. 2 Levin, B., Lieberman, D.A., McFarland, B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134 (2008), 1570–1595.
3. 3 Elmunzer, B.J., Singal, A.G., Sussman, J.B., et al. Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis. Gastrointest Endosc 81 (2015), 700–709.e3.
4. 4 DeBourcy, A.C., Lichtenberger, S., Felton, S., Butterfield, K.T., Ahnen, D.J., Denberg, T.D., Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 23 (2008), 169–174.
5. 5 Hardcastle, J.D., Chamberlain, J.O., Robinson, M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996), 1472–1477.
6. 6 Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O.D., Sondergaard, O., Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996), 1467–1471.
7. 7 El-Serag, H.B., Petersen, L., Hampel, H., Richardson, P., Cooper, G., The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med 166 (2006), 2202–2208.
8. 8 Moiel, D., Thompson, J., Early detection of colon cancer—the Kaiser Permanente Northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients?. Perm J 15 (2011), 30–38.
9. 9 Tiro, J.A., Kamineni, A., Levin, T.R., et al. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev 23 (2014), 1147–1158.
10. 10 Zapka, J., Taplin, S.H., Price, R.A., Cranos, C., Yabroff, R., Factors in quality care–the case of follow-up to abnormal cancer screening tests–problems in the steps and interfaces of care. J Natl Cancer Inst Monogr 2010 (2010), 58–71.
11. 11 Carlson, C.M., Kirby, K.A., Casadei, M.A., Partin, M.R., Kistler, C.E., Walter, L.C., Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?. Arch Intern Med 171 (2011), 249–256.
12. 12 Fisher, D.A., Jeffreys, A., Coffman, C.J., Fasanella, K., Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev 15 (2006), 1232–1235.
13. 13 Gupta, S., Sussman, D.A., Doubeni, C.A., et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst, 106, 2014, dju032.
14. 14 Zapka, J.M., Edwards, H.M., Chollette, V., Taplin, S.H., Follow-up to abnormal cancer screening tests: considering the multilevel context of care. Cancer Epidemiol Biomarkers Prev 23 (2014), 1965–1973.
15. 15 O'Malley, A.S., Beaton, E., Yabroff, K.R., Abramson, R., Mandelblatt, J., Patient and provider barriers to colorectal cancer screening in the primary care safety-net. Prev Med 39 (2004), 56–63.
16. 16 Green, A.R., Peters-Lewis, A., Percac-Lima, S., et al. Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med 23 (2008), 834–840.
17. 17 Ward, E., Halpern, M., Schrag, N., et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58 (2008), 9–31.
18. 18 Beaber, E.F., Kim, J.J., Schapira, M.M., et al. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst, 107, 2015, djv120.
19. 19 Chubak, J., Garcia, M., Burnett-Hartman, A., et al. Time to colonoscopy after positive fecal blood test in four US healthcare systems. Cancer Epidemiol Biomarkers Prev 25:2 (2016), 344–350.
20. 20 Goebel, M., Singal, A.G., Nodora, J., et al. How can we boost colorectal and hepatocellular carcinoma screening among underserved populations?. Curr Gastroenterol Rep, 17, 2015, 22.
21. 21 Gupta, S., Tong, L., Allison, J.E., et al. Screening for colorectal cancer in a safety-net health care system: access to care is critical and has implications for screening policy. Cancer Epidemiol Biomarkers Prev 18 (2009), 2373–2379.
22. 22 Jones, R.M., Devers, K.J., Kuzel, A.J., Woolf, S.H., Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med 38 (2010), 508–516.
23. 23 Jones, R.M., Woolf, S.H., Cunningham, T.D., et al. The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med 38 (2010), 499–507.
24. 24 Bastani, R., Yabroff, K.R., Myers, R.E., Glenn, B., Interventions to improve follow-up of abnormal findings in cancer screening. Cancer 101 (2004), 1188–1200.
25. 25 Yabroff, K.R., Washington, K.S., Leader, A., Neilson, E., Mandelblatt, J., Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev 60 (2003), 294–331.
26. 26 Yabroff, K.R., Kerner, J.F., Mandelblatt, J.S., Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening. Prev Med 31 (2000), 429–439.